Brief: Biomx To Provide Latest Update On Positive Phase 1B/2A Clinical Trial Data For Bx004 At North American Cystic Fibrosis Conference

Biomx

18/09/2024 14:03

Sept 18 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX TO PROVIDE LATEST UPDATE ON POSITIVE PHASE 1B/2A
CLINICAL
TRIAL DATA FOR BX004 AT THE NORTH AMERICAN CYSTIC FIBROSIS
CONFERENCE
    * BIOMX INC - FDA GRANTS BX004 FAST TRACK AND ORPHAN DRUG
DESIGNATION
    * BIOMX INC - TO INITIATE PHASE 2B TRIAL IN CF PATIENTS WITH
P.
AERUGINOSA INFECTIONS

Source text for Eikon:  ID:nGNX7rkx5n 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))